Similarly, as illustrated by Shiah et al. [15], miR-410 attenuated the Wnt-β-catenin pathway in oral squamous cell carcinoma cells by targeting Wnt-7b, an activator of the Wnt-β-catenin pathway. This evidence concerns the gene WNT7B and oral cavity squamous cell carcinoma.